MRSN(Delisted)
Mersana Therapeutics·NASDAQ
--
--(--)
1.58 / 10
Underperform
The equity presents weak fundamental picture (1.6/10). Strengths include Inventory turnover ratio and Days sales outstanding, although drawbacks are visible in Total assets turnover ratio and Total operating revenue (YoY growth rate %). This merits selective consideration.
Analysis Checks(5/10)
Revenue-MV
Value-2.52
Score1/3
Weight35.03%
1M Return5.58%
Value-2.52
Score1/3
Weight35.03%
1M Return5.58%
Days sales outstanding
Value1.35
Score2/3
Weight-7.73%
1M Return-1.64%
Value1.35
Score2/3
Weight-7.73%
1M Return-1.64%
PB-ROE
Value14.39
Score2/3
Weight73.97%
1M Return12.40%
Value14.39
Score2/3
Weight73.97%
1M Return12.40%
Total assets turnover ratio
Value0.16
Score1/3
Weight-6.88%
1M Return-1.53%
Value0.16
Score1/3
Weight-6.88%
1M Return-1.53%
Asset-MV
Value-0.52
Score0/3
Weight35.27%
1M Return5.19%
Value-0.52
Score0/3
Weight35.27%
1M Return5.19%
Total operating revenue (YoY growth rate %)
Value-30.32
Score1/3
Weight-6.07%
1M Return-1.30%
Value-30.32
Score1/3
Weight-6.07%
1M Return-1.30%
Inventory turnover ratio
Value48.24
Score2/3
Weight-6.73%
1M Return-1.46%
Value48.24
Score2/3
Weight-6.73%
1M Return-1.46%
Operating revenue (YoY growth rate %)
Value-30.32
Score1/3
Weight-5.67%
1M Return-1.21%
Value-30.32
Score1/3
Weight-5.67%
1M Return-1.21%
Cost of sales ratio (%)
Value70.68
Score2/3
Weight-6.88%
1M Return-1.49%
Value70.68
Score2/3
Weight-6.88%
1M Return-1.49%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-4.31%
1M Return-0.89%
Value100.00
Score2/3
Weight-4.31%
1M Return-0.89%
Revenue-MV
Value-2.52
Score1/3
Weight35.03%
1M Return5.58%
Value-2.52
Score1/3
Weight35.03%
1M Return5.58%
Total operating revenue (YoY growth rate %)
Value-30.32
Score1/3
Weight-6.07%
1M Return-1.30%
Value-30.32
Score1/3
Weight-6.07%
1M Return-1.30%
Days sales outstanding
Value1.35
Score2/3
Weight-7.73%
1M Return-1.64%
Value1.35
Score2/3
Weight-7.73%
1M Return-1.64%
Inventory turnover ratio
Value48.24
Score2/3
Weight-6.73%
1M Return-1.46%
Value48.24
Score2/3
Weight-6.73%
1M Return-1.46%
PB-ROE
Value14.39
Score2/3
Weight73.97%
1M Return12.40%
Value14.39
Score2/3
Weight73.97%
1M Return12.40%
Operating revenue (YoY growth rate %)
Value-30.32
Score1/3
Weight-5.67%
1M Return-1.21%
Value-30.32
Score1/3
Weight-5.67%
1M Return-1.21%
Total assets turnover ratio
Value0.16
Score1/3
Weight-6.88%
1M Return-1.53%
Value0.16
Score1/3
Weight-6.88%
1M Return-1.53%
Cost of sales ratio (%)
Value70.68
Score2/3
Weight-6.88%
1M Return-1.49%
Value70.68
Score2/3
Weight-6.88%
1M Return-1.49%
Asset-MV
Value-0.52
Score0/3
Weight35.27%
1M Return5.19%
Value-0.52
Score0/3
Weight35.27%
1M Return5.19%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-4.31%
1M Return-0.89%
Value100.00
Score2/3
Weight-4.31%
1M Return-0.89%
Is MRSN fundamentally strong?
- MRSN scores 1.58/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -211.21% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 7.12% earnings growth, these metrics solidify its Underperform investment rating.
